SurgePays
SURG
$4.09
Share price
4.87%
Change (1 day)
-6.19%
Change (1 year)
Categories
P/S ratio for SurgePays (SURG)
P/S ratio as of May 2024 (TTM): 0.5751
According to SurgePays's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.575077. At the end of 2023 the company had a P/S ratio of 0.6692.
P/S ratio history for SurgePays from 2009 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 0.6692 | -1.06% |
| 2022 | 0.6763 | 41.71% |
| 2021 | 0.4773 | 73.83% |
| 2020 | 0.2746 | -76.95% |
| 2019 | 1.19 | -45.74% |
| 2018 | 2.19 | -95.27% |
| 2017 | 46.4 | 900.06% |
| 2016 | 4.64 | -47.6% |
| 2015 | 8.85 | -91.72% |
| 2014 | 107 | 18.99% |
| 2013 | 89.8 | |
| 2011 | 518 | 2104.42% |
| 2010 | 23.5 | -92.66% |
| 2009 | 320 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 4.02 | 599.45% | 🇺🇸 USA |
 Novartis NVS | 4.10 | 612.45% | 🇨🇭 Switzerland |
 Stryker Corporation SYK | 6.01 | 945.52% | 🇺🇸 USA |
 Cooper Companies COO | 5.13 | 792.63% | 🇺🇸 USA |
 STAAR Surgical STAA | 6.53 | 1,035.71% | 🇺🇸 USA |
 CONMED CNMD | 1.72 | 198.63% | 🇺🇸 USA |
 Integra LifeSciences IART | 1.29 | 124.88% | 🇺🇸 USA |